Ed Schwalbe

Ed Schwalbe

Northumbria University

H-index: 28

Europe-United Kingdom

About Ed Schwalbe

Ed Schwalbe, With an exceptional h-index of 28 and a recent h-index of 23 (since 2020), a distinguished researcher at Northumbria University, specializes in the field of Bioinformatics, Oncology, Cancer Genomics, Cancer Epigenomics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Bone Proteomics Method Optimization for Forensic Investigations

The clinical significance of sub-total surgical resection in childhood medulloblastoma: a multi-cohort analysis of 1100 patients

Metabolite profiles of medulloblastoma for rapid and non-invasive detection of molecular disease groups

Clinical outcome of pediatric medulloblastoma patients with Li–Fraumeni syndrome

Deriving a continuum score for group 3 and 4 medulloblastoma tumor samples analyzed via RNA-sequencing or DNA methylation microarray

MDB-15. CLINICAL CHARACTERISTICS AND OUTCOME OF CHILDHOOD LI-FRAUMENI SYNDROME MEDULLOBLASTOMA PATIENTS

Timing is everything: A connection between medulloblastoma prognosis and foetal cerebellar development

Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification

Ed Schwalbe Information

University

Position

___

Citations(all)

4372

Citations(since 2020)

2274

Cited By

2961

hIndex(all)

28

hIndex(since 2020)

23

i10Index(all)

46

i10Index(since 2020)

40

Email

University Profile Page

Google Scholar

Ed Schwalbe Skills & Research Interests

Bioinformatics

Oncology

Cancer Genomics

Cancer Epigenomics

Top articles of Ed Schwalbe

Bone Proteomics Method Optimization for Forensic Investigations

Journal of Proteome Research

2024/4/15

The clinical significance of sub-total surgical resection in childhood medulloblastoma: a multi-cohort analysis of 1100 patients

Eclinicalmedicine

2024/3/1

Deriving a continuum score for group 3 and 4 medulloblastoma tumor samples analyzed via RNA-sequencing or DNA methylation microarray

STAR protocols

2023/9/15

MDB-15. CLINICAL CHARACTERISTICS AND OUTCOME OF CHILDHOOD LI-FRAUMENI SYNDROME MEDULLOBLASTOMA PATIENTS

Neuro-Oncology

2023/6/1

Timing is everything: A connection between medulloblastoma prognosis and foetal cerebellar development

2023/6

Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification

Acta neuropathologica

2023/5

The impact of maceration on the ‘Osteo-ome’; a pilot investigation

Journal of Proteomics

2023/1/16

The Idiopathic Pulmonary Fibrosis-associated single nucleotide polymorphism rs35705950 is transcribed in a MUC5B Promoter Associated Long Non-Coding RNA (AC061979. 1)

Non-coding RNA

2022/12/8

Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma

British Journal of Cancer

2022/11/23

Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development

Acta neuropathologica

2022/9

Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development

Cell reports

2022/8/2

MEDB-36. Clinical and molecular heterogeneity withinMYC andMYCN amplified medulloblastoma

Neuro-Oncology

2022/6/3

PATH-06. Molecular subgrouping of medulloblastoma via low-depth whole genome bisulfite sequencing

Neuro-Oncology

2022/6

MOLECULAR CHARACTERISATION OF GROUP 4 MEDULLOBLASTOMA IMPROVES RISK-STRATIFICATION AND ITS BIOLOGICAL UNDERSTANDING

2022/6/1

MEDB-43. Development of a bioinformatics pipeline for identification of differential DNA methylation events associated with medulloblastoma relapse

Neuro-Oncology

2022/6/1

MEDB-65. Molecular subclassification of a national cohort of pediatric medulloblastoma based on methylation profile

Neuro-Oncology

2022/6/1

RARE-08. Profiling of recurrent adamantinomatous cranionpharyngioma confirms the activation of the MAPK pathway and identifies copy number aberrations in relapsed tumours

Neuro-Oncology

2022/6/1

See List of Professors in Ed Schwalbe University(Northumbria University)